Published in BMC Microbiol on June 15, 2010
Detection of staphylococcal cassette chromosome mec type XI carrying highly divergent mecA, mecI, mecR1, blaZ, and ccr genes in human clinical isolates of clonal complex 130 methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2011) 3.60
Rare occurrence of methicillin-resistant Staphylococcus aureus CC130 with a novel mecA homologue in humans in Germany. PLoS One (2011) 2.18
Identification of a highly transmissible animal-independent Staphylococcus aureus ST398 clone with distinct genomic and cell adhesion properties. MBio (2012) 2.00
Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood. PLoS Pathog (2011) 1.57
The distribution of mobile genetic elements (MGEs) in MRSA CC398 is associated with both host and country. Genome Biol Evol (2011) 1.53
Staphylococcal manipulation of host immune responses. Nat Rev Microbiol (2015) 1.42
Where does a Staphylococcus aureus vaccine stand? Clin Microbiol Infect (2014) 1.18
Extensive horizontal gene transfer during Staphylococcus aureus co-colonization in vivo. Genome Biol Evol (2014) 1.13
The distribution of plasmids that carry virulence and resistance genes in Staphylococcus aureus is lineage associated. BMC Microbiol (2012) 1.08
Staphylococcus aureus temperate bacteriophage: carriage and horizontal gene transfer is lineage associated. Front Cell Infect Microbiol (2012) 1.08
Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humans. Clin Vaccine Immunol (2010) 1.07
Protein A-specific monoclonal antibodies and prevention of Staphylococcus aureus disease in mice. Infect Immun (2012) 1.06
Host- and microbe determinants that may influence the success of S. aureus colonization. Front Cell Infect Microbiol (2012) 1.03
Phagocytosis escape by a Staphylococcus aureus protein that connects complement and coagulation proteins at the bacterial surface. PLoS Pathog (2013) 1.02
Coagulases as determinants of protective immune responses against Staphylococcus aureus. Infect Immun (2012) 1.02
Vaccines, reverse vaccinology, and bacterial pathogenesis. Cold Spring Harb Perspect Med (2013) 1.01
Detection of mobile-genetic-element variation between colonizing and infecting hospital-associated methicillin-resistant Staphylococcus aureus isolates. J Clin Microbiol (2011) 0.99
Survival of Staphylococcus aureus ST398 in the human nose after artificial inoculation. PLoS One (2012) 0.94
Genomic and surface proteomic analysis of the canine pathogen Staphylococcus pseudintermedius reveals proteins that mediate adherence to the extracellular matrix. Infect Immun (2011) 0.93
Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue. Microbiology (2014) 0.93
Are nasal carriers of Staphylococcus aureus more likely to become colonized or infected with methicillin-resistant Staphylococcus aureus on admission to a hospital? J Clin Microbiol (2010) 0.93
Characterization of a mouse-adapted Staphylococcus aureus strain. PLoS One (2013) 0.91
Identification of staphylococcal phage with reduced transcription in human blood through transcriptome sequencing. Front Microbiol (2015) 0.90
Staphylococcus aureus virulence is enhanced by secreted factors that block innate immune defenses. J Innate Immun (2012) 0.89
Shuffling of mobile genetic elements (MGEs) in successful healthcare-associated MRSA (HA-MRSA). Mob Genet Elements (2012) 0.89
Nasopharyngeal colonization elicits antibody responses to staphylococcal and pneumococcal proteins that are not associated with a reduced risk of subsequent carriage. Infect Immun (2012) 0.89
Impact of target site distribution for Type I restriction enzymes on the evolution of methicillin-resistant Staphylococcus aureus (MRSA) populations. Nucleic Acids Res (2013) 0.88
Leukocidin genes lukF-P83 and lukM are associated with Taphylococcus aureus clonal complexes 151, 479 and 133 isolated from bovine udder infections in Thuringia, Germany. Vet Res (2012) 0.88
Comparative host specificity of human- and pig- associated Staphylococcus aureus clonal lineages. PLoS One (2012) 0.87
Proteomic and transcriptomic profiling of Staphylococcus aureus surface LPXTG-proteins: correlation with agr genotypes and adherence phenotypes. Mol Cell Proteomics (2012) 0.87
Sequence diversities of serine-aspartate repeat genes among Staphylococcus aureus isolates from different hosts presumably by horizontal gene transfer. PLoS One (2011) 0.87
Complete Genome Sequence of a Variant of the Methicillin-Resistant Staphylococcus aureus ST239 Lineage, Strain BMB9393, Displaying Superior Ability To Accumulate ica-Independent Biofilm. Genome Announc (2013) 0.86
Staphylococcus aureus genomic pattern and atopic dermatitis: may factors other than superantigens be involved? Eur J Clin Microbiol Infect Dis (2013) 0.86
The sortase A substrates FnbpA, FnbpB, ClfA and ClfB antagonize colony spreading of Staphylococcus aureus. PLoS One (2012) 0.86
A Diagnostic Serum Antibody Test for Patients With Staphylococcus aureus Osteomyelitis. Clin Orthop Relat Res (2015) 0.85
Naturally occurring IgG antibody levels to the Staphylococcus aureus protein IsdB in humans. Hum Vaccin Immunother (2013) 0.84
Protective activity of the CnaBE3 domain conserved among Staphylococcus aureus Sdr proteins. PLoS One (2013) 0.84
Community-associated methicillin-resistant Staphylococcus aureus clonal complex 80 type IV (CC80-MRSA-IV) isolated from the Middle East: a heterogeneous expanding clonal lineage. PLoS One (2014) 0.84
Clonal diversity and epidemiological characteristics of Staphylococcus aureus: high prevalence of oxacillin-susceptible mecA-positive Staphylococcus aureus (OS-MRSA) associated with clinical isolates in Brazil. BMC Microbiol (2016) 0.84
The Staphylococcus aureus ArlRS two-component system is a novel regulator of agglutination and pathogenesis. PLoS Pathog (2013) 0.84
Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection. PLoS Pathog (2015) 0.82
Staphylococcus aureus vaccines: Deviating from the carol. J Exp Med (2016) 0.82
CD4 T cell antigens from Staphylococcus aureus Newman strain identified following immunization with heat-killed bacteria. Clin Vaccine Immunol (2012) 0.82
Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model. Infect Immun (2014) 0.81
A structurally dynamic N-terminal helix is a key functional determinant in staphylococcal complement inhibitor (SCIN) proteins. J Biol Chem (2012) 0.81
The giant protein Ebh is a determinant of Staphylococcus aureus cell size and complement resistance. J Bacteriol (2013) 0.80
Serological profiles in nursery piglets colonized with Staphylococcus aureus. Vet Res (2013) 0.79
Peptidoglycan-linked protein A promotes T cell-dependent antibody expansion during Staphylococcus aureus infection. Proc Natl Acad Sci U S A (2016) 0.77
Genomic, Transcriptomic and Metabolomic Studies of Two Well-Characterized, Laboratory-Derived Vancomycin-Intermediate Staphylococcus aureus Strains Derived from the Same Parent Strain. Antibiotics (Basel) (2015) 0.77
Immunogenicity analysis of Staphylococcus aureus clumping factor A genetic variants. Clin Vaccine Immunol (2013) 0.77
Adhesive polypeptides of Staphylococcus aureus identified using a novel secretion library technique in Escherichia coli. BMC Microbiol (2011) 0.77
Characterization of the biological anti-staphylococcal functionality of hUK-66 IgG1, a humanized monoclonal antibody as substantial component for an immunotherapeutic approach. Hum Vaccin Immunother (2014) 0.76
Combining in vitro protein detection and in vivo antibody detection identifies potential vaccine targets against Staphylococcus aureus during osteomyelitis. Med Microbiol Immunol (2016) 0.76
DNA target recognition domains in the Type I restriction and modification systems of Staphylococcus aureus. Nucleic Acids Res (2017) 0.75
Genomic and transcriptomic comparison between Staphylococcus aureus strains associated with high and low within herd prevalence of intra-mammary infection. BMC Microbiol (2017) 0.75
Laboratory Mice Are Frequently Colonized with Staphylococcus aureus and Mount a Systemic Immune Response-Note of Caution for In vivo Infection Experiments. Front Cell Infect Microbiol (2017) 0.75
Serine-aspartate-repeat protein D Increases Staphylococcus aureus Virulence and Survival in Blood. Infect Immun (2016) 0.75
A review on host-pathogen interactions: classification and prediction. Eur J Clin Microbiol Infect Dis (2016) 0.75
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protoc (2007) 19.50
Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet (2001) 18.55
Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet (2006) 15.99
Genome and virulence determinants of high virulence community-acquired MRSA. Lancet (2002) 14.64
Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev (1997) 12.33
Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci U S A (2004) 8.95
How clonal is Staphylococcus aureus? J Bacteriol (2003) 7.97
Surface protein adhesins of Staphylococcus aureus. Trends Microbiol (1998) 6.86
Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci U S A (2007) 6.14
Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall. Science (1999) 5.98
Complete sequence of the staphylococcal gene encoding protein A. A gene evolved through multiple duplications. J Biol Chem (1984) 5.94
Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2003) 5.29
Passage of heme-iron across the envelope of Staphylococcus aureus. Science (2003) 4.83
Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J Bacteriol (2007) 4.07
Methicillin-resistant Staphylococcus aureus ST398 in humans and animals, Central Europe. Emerg Infect Dis (2007) 4.04
Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med (2008) 4.01
Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis (2007) 3.98
Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat Med (2004) 3.84
Community-acquired MRSA and pig-farming. Ann Clin Microbiol Antimicrob (2006) 3.80
Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus. Mol Microbiol (1998) 3.79
The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. J Bacteriol (2006) 3.50
Evolution of Staphylococcus aureus by large chromosomal replacements. J Bacteriol (2004) 3.33
Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus. BMC Microbiol (2007) 3.25
Recent human-to-poultry host jump, adaptation, and pandemic spread of Staphylococcus aureus. Proc Natl Acad Sci U S A (2009) 3.10
Molecular characterization and expression of a gene encoding a Staphylococcus aureus collagen adhesin. J Biol Chem (1992) 2.99
Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus. Microbiology (1998) 2.82
Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J (2009) 2.82
Genome sequence of a recently emerged, highly transmissible, multi-antibiotic- and antiseptic-resistant variant of methicillin-resistant Staphylococcus aureus, sequence type 239 (TW). J Bacteriol (2009) 2.81
Vaccine assembly from surface proteins of Staphylococcus aureus. Proc Natl Acad Sci U S A (2006) 2.71
An outbreak in an intensive care unit of a strain of methicillin-resistant Staphylococcus aureus sequence type 239 associated with an increased rate of vascular access device-related bacteremia. Clin Infect Dis (2007) 2.64
Staphylococcus aureus host specificity: comparative genomics of human versus animal isolates by multi-strain microarray. Microbiology (2008) 2.51
EsxA and EsxB are secreted by an ESAT-6-like system that is required for the pathogenesis of Staphylococcus aureus infections. Proc Natl Acad Sci U S A (2005) 2.42
A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model. Infect Immun (2006) 2.41
Molecular correlates of host specialization in Staphylococcus aureus. PLoS One (2007) 2.41
The fibronectin-binding MSCRAMM FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen. J Biol Chem (2000) 2.39
Prevalence of methicillin-resistant Staphylococcus aureus among staff and pets in a small animal referral hospital in the UK. J Antimicrob Chemother (2005) 2.38
Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance. Antimicrob Agents Chemother (2007) 2.33
The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation. Microbiology (2007) 2.15
A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. Infect Immun (1996) 2.13
Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. Blood (2000) 2.12
Methicillin-resistant staphylococci in companion animals. Emerg Infect Dis (2005) 2.07
Staphylococcal complement evasion by various convertase-blocking molecules. J Exp Med (2007) 2.03
Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen. Eur J Biochem (1997) 2.01
Role of SraP, a Serine-Rich Surface Protein of Staphylococcus aureus, in binding to human platelets. Infect Immun (2005) 1.99
Characterization of novel LPXTG-containing proteins of Staphylococcus aureus identified from genome sequences. Microbiology (2003) 1.98
Mapping the pathways to staphylococcal pathogenesis by comparative secretomics. Microbiol Mol Biol Rev (2006) 1.93
Staphylococcus aureus synthesizes adenosine to escape host immune responses. J Exp Med (2009) 1.85
Structure of the collagen-binding domain from a Staphylococcus aureus adhesin. Nat Struct Biol (1997) 1.80
A 'Collagen Hug' model for Staphylococcus aureus CNA binding to collagen. EMBO J (2005) 1.78
Surface adhesins of Staphylococcus aureus. Adv Microb Physiol (2006) 1.77
Cloning and characterization of a gene for a 19 kDa fibrinogen-binding protein from Staphylococcus aureus. Mol Microbiol (1994) 1.77
Design, validation, and application of a seven-strain Staphylococcus aureus PCR product microarray for comparative genomics. Appl Environ Microbiol (2005) 1.73
Surface proteins that promote adherence of Staphylococcus aureus to human desquamated nasal epithelial cells. BMC Microbiol (2009) 1.68
Human factor in Staphylococcus aureus nasal carriage. Infect Immun (2004) 1.64
Analysis of Ebh, a 1.1-megadalton cell wall-associated fibronectin-binding protein of Staphylococcus aureus. Infect Immun (2002) 1.63
Crystal structures of fibronectin-binding sites from Staphylococcus aureus FnBPA in complex with fibronectin domains. Proc Natl Acad Sci U S A (2008) 1.62
The clinical significance of methicillin-resistant Staphylococcus aureus. J Hosp Infect (2005) 1.60
Identification and characterization of a novel 38.5-kilodalton cell surface protein of Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and plasma proteins. J Bacteriol (2001) 1.56
Identification and characterization of the C3 binding domain of the Staphylococcus aureus extracellular fibrinogen-binding protein (Efb). J Biol Chem (2004) 1.55
A structural model of the Staphylococcus aureus ClfA-fibrinogen interaction opens new avenues for the design of anti-staphylococcal therapeutics. PLoS Pathog (2008) 1.55
IsdA of Staphylococcus aureus is a broad spectrum, iron-regulated adhesin. Mol Microbiol (2004) 1.50
The multifunctional Staphylococcus aureus autolysin aaa mediates adherence to immobilized fibrinogen and fibronectin. Infect Immun (2005) 1.43
Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus. J Biol Chem (2008) 1.42
The N-terminal A domain of fibronectin-binding proteins A and B promotes adhesion of Staphylococcus aureus to elastin. J Biol Chem (2004) 1.42
A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1. J Immunol (2006) 1.40
The elastin-binding protein of Staphylococcus aureus (EbpS) is expressed at the cell surface as an integral membrane protein and not as a cell wall-associated protein. J Biol Chem (2001) 1.37
Community-associated methicillin-resistant Staphylococcus aureus in horses and humans who work with horses. J Am Vet Med Assoc (2005) 1.37
Signal peptides direct surface proteins to two distinct envelope locations of Staphylococcus aureus. EMBO J (2008) 1.35
The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b. PLoS Pathog (2008) 1.34
Multiple binding sites in the interaction between an extracellular fibrinogen-binding protein from Staphylococcus aureus and fibrinogen. J Biol Chem (1998) 1.32
A novel von Willebrand factor binding protein expressed by Staphylococcus aureus. Microbiology (2002) 1.31
EsaC substrate for the ESAT-6 secretion pathway and its role in persistent infections of Staphylococcus aureus. Mol Microbiol (2008) 1.30
Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid. J Clin Microbiol (2009) 1.30
Von Willebrand factor-binding protein is a hysteretic conformational activator of prothrombin. Proc Natl Acad Sci U S A (2009) 1.28
Fibrinogen and elastin bind to the same region within the A domain of fibronectin binding protein A, an MSCRAMM of Staphylococcus aureus. Mol Microbiol (2007) 1.26
Molecular characterization of a novel Staphylococcus aureus surface protein (SasC) involved in cell aggregation and biofilm accumulation. PLoS One (2009) 1.21
The binding of calcium to the B-repeat segment of SdrD, a cell surface protein of Staphylococcus aureus. J Biol Chem (1998) 1.18
Rapid determination of hospital-acquired meticillin-resistant Staphylococcus aureus lineages. J Med Microbiol (2007) 1.17
Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for Staphylococcus aureus virulence. PLoS One (2008) 1.14
Genetic diversity of staphylocoagulase genes (coa): insight into the evolution of variable chromosomal virulence factors in Staphylococcus aureus. PLoS One (2009) 1.14
Staphylococcus aureus protein A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regions. FEBS J (2006) 1.13
Occurrence of methicillin-resistant Staphylococcus aureus in rats living on pig farms. Prev Vet Med (2009) 1.13
Structural comparison of ten serotypes of staphylocoagulases in Staphylococcus aureus. J Bacteriol (2005) 1.11
More than one tandem repeat domain of the extracellular adherence protein of Staphylococcus aureus is required for aggregation, adherence, and host cell invasion but not for leukocyte activation. Infect Immun (2008) 1.09
Iron-regulated surface determinant protein A mediates adhesion of Staphylococcus aureus to human corneocyte envelope proteins. Infect Immun (2009) 1.09
Genomic analysis of an emerging multiresistant Staphylococcus aureus strain rapidly spreading in cystic fibrosis patients revealed the presence of an antibiotic inducible bacteriophage. Biol Direct (2009) 1.07
Genetic diversity in CC398 methicillin-resistant Staphylococcus aureus isolates of different geographical origin. Clin Microbiol Infect (2009) 1.05
eap Gene as novel target for specific identification of Staphylococcus aureus. J Clin Microbiol (2007) 1.03
Vaccination as infection control: a pilot study to determine the impact of Staphylococcus aureus vaccination on nasal carriage. Vaccine (2009) 1.03
Identification of the Staphylococcus aureus MSCRAMM clumping factor B (ClfB) binding site in the alphaC-domain of human fibrinogen. Microbiology (2008) 1.03
Vaccination with clumping factor A and fibronectin binding protein A to prevent Staphylococcus aureus infection of an aortic patch in mice. J Infect Dis (2008) 1.03
Immune evasion by Staphylococcus aureus conferred by iron-regulated surface determinant protein IsdH. Microbiology (2009) 1.02
Fibronectin-binding proteins and fibrinogen-binding clumping factors play distinct roles in staphylococcal arthritis and systemic inflammation. J Infect Dis (2005) 0.98
Isolation and characterisation of a vitronectin-binding surface protein from Staphylococcus aureus. Biochim Biophys Acta (1995) 0.96
Structure-function analysis of the C3 binding region of Staphylococcus aureus immune subversion protein Sbi. J Biol Chem (2008) 0.96
An outbreak of severe infections with community-acquired MRSA carrying the Panton-Valentine leukocidin following vaccination. PLoS One (2007) 0.95
Difference in virulence between Staphylococcus aureus isolates causing gangrenous mastitis versus subclinical mastitis in a dairy sheep flock. Vet Res (2009) 0.95
Sequence diversity in the A domain of Staphylococcus aureus fibronectin-binding protein A. BMC Microbiol (2008) 0.94
Evolution of MRSA during hospital transmission and intercontinental spread. Science (2010) 13.34
Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci U S A (2004) 8.95
Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods. Int J Antimicrob Agents (2012) 3.03
Sau1: a novel lineage-specific type I restriction-modification system that blocks horizontal gene transfer into Staphylococcus aureus and between S. aureus isolates of different lineages. J Bacteriol (2006) 2.93
Genome sequence of a recently emerged, highly transmissible, multi-antibiotic- and antiseptic-resistant variant of methicillin-resistant Staphylococcus aureus, sequence type 239 (TW). J Bacteriol (2009) 2.81
An outbreak in an intensive care unit of a strain of methicillin-resistant Staphylococcus aureus sequence type 239 associated with an increased rate of vascular access device-related bacteremia. Clin Infect Dis (2007) 2.64
Staphylococcus aureus host specificity: comparative genomics of human versus animal isolates by multi-strain microarray. Microbiology (2008) 2.51
Prevalence of methicillin-resistant Staphylococcus aureus among staff and pets in a small animal referral hospital in the UK. J Antimicrob Chemother (2005) 2.38
Identification of a highly transmissible animal-independent Staphylococcus aureus ST398 clone with distinct genomic and cell adhesion properties. MBio (2012) 2.00
Evolutionary genomics of Staphylococcus aureus reveals insights into the origin and molecular basis of ruminant host adaptation. Genome Biol Evol (2010) 1.81
Design, validation, and application of a seven-strain Staphylococcus aureus PCR product microarray for comparative genomics. Appl Environ Microbiol (2005) 1.73
Rapid PCR detection of Staphylococcus aureus clonal complex 398 by targeting the restriction-modification system carrying sau1-hsdS1. J Clin Microbiol (2010) 1.62
Association of mannose-binding lectin deficiency with acute invasive aspergillosis in immunocompromised patients. Clin Infect Dis (2009) 1.55
The distribution of mobile genetic elements (MGEs) in MRSA CC398 is associated with both host and country. Genome Biol Evol (2011) 1.53
Anti-MRSA agent discovery using diversity-oriented synthesis. Angew Chem Int Ed Engl (2008) 1.47
Two distinct clones of methicillin-resistant Staphylococcus aureus (MRSA) with the same USA300 pulsed-field gel electrophoresis profile: a potential pitfall for identification of USA300 community-associated MRSA. J Clin Microbiol (2009) 1.25
The Staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications. PLoS One (2009) 1.19
Rapid determination of hospital-acquired meticillin-resistant Staphylococcus aureus lineages. J Med Microbiol (2007) 1.17
Major families of multiresistant plasmids from geographically and epidemiologically diverse staphylococci. G3 (Bethesda) (2011) 1.14
Staphylococcus aureus strains that are hypersusceptible to resistance gene transfer from enterococci. Antimicrob Agents Chemother (2007) 1.14
Shift in dominant hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones over time. J Antimicrob Chemother (2012) 1.12
Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose. Thorax (2013) 1.12
Staphylococcus aureus CC398 clade associated with human-to-human transmission. Appl Environ Microbiol (2012) 1.10
The distribution of plasmids that carry virulence and resistance genes in Staphylococcus aureus is lineage associated. BMC Microbiol (2012) 1.08
Staphylococcus aureus temperate bacteriophage: carriage and horizontal gene transfer is lineage associated. Front Cell Infect Microbiol (2012) 1.08
Staphylococcus aureus innate immune evasion is lineage-specific: a bioinfomatics study. Infect Genet Evol (2013) 1.01
Detection of mobile-genetic-element variation between colonizing and infecting hospital-associated methicillin-resistant Staphylococcus aureus isolates. J Clin Microbiol (2011) 0.99
Are all meticillin-resistant Staphylococcus aureus (MRSA) equal in all hosts? Epidemiological and genetic comparison between animal and human MRSA. Vet Dermatol (2012) 0.95
Survival of Staphylococcus aureus ST398 in the human nose after artificial inoculation. PLoS One (2012) 0.94
Are nasal carriers of Staphylococcus aureus more likely to become colonized or infected with methicillin-resistant Staphylococcus aureus on admission to a hospital? J Clin Microbiol (2010) 0.93
Characterization and comparison of 2 distinct epidemic community-associated methicillin-resistant Staphylococcus aureus clones of ST59 lineage. PLoS One (2013) 0.92
Impact of target site distribution for Type I restriction enzymes on the evolution of methicillin-resistant Staphylococcus aureus (MRSA) populations. Nucleic Acids Res (2013) 0.88
Comparative host specificity of human- and pig- associated Staphylococcus aureus clonal lineages. PLoS One (2012) 0.87
Genetic variation in spatio-temporal confined USA300 community-associated MRSA isolates: a shift from clonal dispersion to genetic evolution? PLoS One (2011) 0.85
Large mobile genetic elements carrying resistance genes that do not confer a fitness burden in healthcare-associated meticillin-resistant Staphylococcus aureus. Microbiology (2013) 0.83
Fructose transport-deficient Staphylococcus aureus reveals important role of epithelial glucose transporters in limiting sugar-driven bacterial growth in airway surface liquid. Cell Mol Life Sci (2014) 0.82
New methods to analyse microarray data that partially lack a reference signal. BMC Genomics (2009) 0.81
Prospects for a MRSA vaccine. Future Microbiol (2007) 0.79
Clones and drones: do variants of Panton-Valentine leukocidin extend the reach of community-associated methicillin-resistant Staphylococcus aureus? J Infect Dis (2008) 0.78
Whole-genome comparison of meticillin-resistant Staphylococcus aureus CC22 SCCmecIV from people and their in-contact pets. Vet Dermatol (2013) 0.76
Reduced sensitivity of oxacillin-screening agar for detection of MRSA ST398 from colonized pigs. J Clin Microbiol (2011) 0.75